Pune, May 17 (IANS) Serum Institute of India (SII), the
world’s largest vaccine manufacturer, on Friday announced a strategic
investment in IntegriMedical to advance Needle-Free
Injection System (N-FIS) technology.
With the investment, SII will acquire a 20 per cent stake in
IntegriMedical. The investment will also accelerate the development and
commercialisation of the N-FIS technology, making it more widely accessible to
patients in India and worldwide“At SII, we are constantly seeking opportunities
to invest in technologies that align with our mission to make healthcare
accessible and affordable for people worldwide.
Read more@ https://hiindia.com/sii-invests-in-integrimedical-to-advance-indias-1st-needle-free-tech-20240517103607-11/
Comments
Post a Comment